Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing,Journal of Clinical Laboratory Analysis

当前位置： X-MOL 学术 › J. Clin. Lab. Anal. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing
Journal of Clinical Laboratory Analysis ( IF 2.7 ) Pub Date : 2024-03-20 , DOI: 10.1002/jcla.25027
Min Ji Jeon ₁ , Eun Sang Yu ₁ , Dae Sik Kim ₁ , Chul Won Choi ₁ , Ha Nui Kim ₂ , Jung Ah Kwon ₂ , Soo‐Young Yoon ₂ , Jung Yoon ₂

Affiliation

Assessment of bone marrow involvement (BMI) in non-Hodgkin lymphoma (NHL) is crucial for determining patient prognosis and treatment strategy. We assessed the prognostic value of next-generation sequencing (NGS)–based immunoglobulin (Ig) gene clonality analysis as an ancillary test for BMI evaluation in NHL.

中文翻译：

使用免疫球蛋白基因重排分析和新一代测序评估 B 细胞非霍奇金淋巴瘤的骨髓受累情况

非霍奇金淋巴瘤 (NHL) 的骨髓受累 (BMI) 评估对于确定患者预后和治疗策略至关重要。我们评估了基于下一代测序 (NGS) 的免疫球蛋白 (Ig) 基因克隆分析作为 NHL BMI 评估的辅助测试的预后价值。

更新日期：2024-03-20

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>